You are using an outdated browser. Please upgrade your browser to improve your experience.

fetal hydantoin syndrome

Disease Summary
Associated Targets (0)

Explore Associated Targets
Mondo Description Fetal hydantoin syndrome is a drug-related embryofetopathy that can occur when an embryo/fetus is exposed to the anticonvulsant drug phenytoin, characterized by distinct craniofacial anomalies (hypertelorism and epicanthal folds, short nose and deep nasal bridge, malformed and low set ears, short neck) as well as hypoplastic distal phalanges and underdevelopment of nails of fingers and toes, prenatal and postnatal growth retardation, and neurological impairment (at a 2-3 times higher risk than that of the general population) including cognitive deficits and motor developmental delay. Less commonly, microcephaly, ocular defects, oral clefts, umbilical and inguinal hernias, hypospadias and cardiac anomalies have also been reported.
Mondo Term and Equivalent IDs
MONDO:0016008:  fetal hydantoin syndrome
GARD:0006435: 
ICD10:Q86.1: 
MESH:C537922: 
NCIT:C98927: 
Orphanet:1912: 
SCTID:70065001: 
UMLS:C0265372: 
GWAS Targets (0)
No GWAS traits found
Target Novelty (Tin-x)
No novelty measurements found